October 14, 2025

NeoGenomics, Inc. (NEO) Stock Analysis: A Healthcare Diagnostics Player with a 7% Upside Potential

NeoGenomics, Inc. (NASDAQ: NEO), a key player in the healthcare sector, operates a sophisticated network of cancer-focused testing laboratories across the United States and the United Kingdom. With a current..

Healthcare Services Group, Inc. (HCSG): Investor Outlook on a Robust 15% Upside Potential

Healthcare Services Group, Inc. (NASDAQ: HCSG) is emerging as a crucial player within the healthcare sector, particularly in the specialized niche of medical care facilities. This Pennsylvania-based company, with a..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Exploring a 77% Potential Upside Amidst Clinical Advancements

Viridian Therapeutics, Inc. (NASDAQ: VRDN) stands as a promising player in the biotechnology sector, capturing the interest of investors with its focus on developing transformative treatments for serious and rare..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating the Challenges with an 18.39% Upside Potential

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the healthcare sector, specifically within the medical devices industry, is currently navigating a challenging market environment. With a market capitalization..

89bio, Inc. (ETNB) Stock Analysis: Potential 97.97% Upside in the Biotech Arena

89bio, Inc. (NASDAQ: ETNB), a dynamic player in the biotechnology sector, is garnering significant attention from investors due to its promising potential upside and robust pipeline. With a market capitalization..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a Potential 38% Upside in the Healthcare Sector

Investors looking for opportunities in the healthcare sector might find Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) an intriguing candidate, particularly given its potential upside of 38.24%. With a current market capitalization..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a Biotech with Strong Buy Ratings and Promising Clinical Pipeline

Mineralys Therapeutics, Inc. (NASDAQ: MLYS), a promising name in the biotechnology sector, has caught the attention of investors with its innovative approach to tackling cardiorenal diseases driven by dysregulated aldosterone...

AtriCure, Inc. (ATRC)

⚠️ No article content returned.

..

Azenta, Inc. (AZTA) Stock Analysis: Navigating Potential Upside in Healthcare Innovation

Azenta, Inc. (NASDAQ: AZTA) is positioned at the intersection of healthcare innovation, offering a range of biological and chemical compound sample management solutions. With a market capitalization of $1.4 billion,..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A Promising 35% Upside in the Healthcare Sector

Establishment Labs Holdings Inc (NASDAQ: ESTA) is carving out a significant niche in the healthcare sector with its innovative medical devices tailored for aesthetic and reconstructive plastic surgeries. Headquartered in..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Unveiling an 84.95% Potential Upside Amid Biotech Innovations

Ocular Therapeutix, Inc. (NASDAQ: OCUL) stands out in the biotechnology sector by leveraging its innovative bioresorbable hydrogel-based formulation technology to tackle retinal diseases and other ocular conditions. The company’s focus..

Immunocore Holdings plc (IMCR) Stock Analysis: Navigating a Potential 92% Upside in the Biotech Arena

Immunocore Holdings plc (NASDAQ: IMCR), a compelling player within the biotechnology sector, has caught the attention of the investment community with its promising pipeline of immunotherapies and a significant potential..

Progyny, Inc. (PGNY) Stock Analysis: Exploring a 38% Upside Potential in the Healthcare Sector

Progyny, Inc. (NASDAQ: PGNY) represents a promising investment opportunity in the healthcare sector, particularly for those focusing on innovative fertility and family-building solutions. With a market capitalization of $1.76 billion,..

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Highs of a $2.54 Billion Market Cap with a Potential Downside

GRAIL, Inc. (NASDAQ: GRAL), a prominent player in the healthcare sector, specifically in diagnostics and research, has been capturing investor attention with its pioneering multi-cancer early detection tests. As the..

National HealthCare Corporation (NHC): Unpacking the Growth Potential in a Thriving Healthcare Sector

National HealthCare Corporation (NYSE: NHC), a key player in the healthcare sector, stands out with its comprehensive range of services spanning skilled nursing facilities, assisted and independent living facilities, and..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 140% Potential Upside Amidst Challenges

Opko Health, Inc. (NASDAQ: OPK), a healthcare company specializing in diagnostics and pharmaceuticals, presents an intriguing prospect for investors willing to navigate the complexities of its financial landscape. While the..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Promising Growth in Autoimmune Therapeutics Sector

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), a Canadian biotechnology firm, has captured investor attention with its innovative approach to treating autoimmune diseases, particularly through its flagship product, LUPKYNIS. As the healthcare..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a Potential 68.58% Upside in the Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is capturing investor attention with a compelling potential upside of 68.58%, according to recent analyst ratings. As a key player in the healthcare sector, specifically..

Teladoc Health, Inc. (TDOC) Stock Analysis: Navigating Challenges with a Potential 11% Upside

Teladoc Health, Inc. (NYSE: TDOC), a prominent player in the burgeoning field of virtual healthcare, offers a compelling yet complex picture for potential investors. With a market capitalization of $1.46..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Unveiling a 186.67% Potential Upside in the Biotech Arena

Investors with a keen eye on the healthcare sector might find ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) an intriguing prospect. As a burgeoning player in the biotechnology industry, ARS Pharmaceuticals offers..

Search

Funds

October 14, 2025

Search

Funds

October 14, 2025

FTSE 100

Funds